Phase II study of VERO SBRT for oligometastatic cancer: First clinical results

B. Engels; R. Van den Begin; T. Depuydt; T. De Vin; T. Gevaert; M. Duchateau; C. Collen; D. Verellen; M. De Ridder

Phase II study of VERO SBRT for oligometastatic cancer: First clinical results

B. Engels, R. Van den Begin, T. Depuydt, T. De Vin, T. Gevaert, M. Duchateau, C. Collen, D. Verellen, M. De Ridder

Research output: Contribution to journal › Article › peer-review

Original language	English
Journal	Radiotherapy and Oncology
Publication status	Published - 2014

Handle.net

Persistent link

Cite this

@article{8c650cdf875540b6adf3b67b0314b5f9,

title = "Phase II study of VERO SBRT for oligometastatic cancer: First clinical results",

author = "B. Engels and {Van den Begin}, R. and T. Depuydt and {De Vin}, T. and T. Gevaert and M. Duchateau and C. Collen and D. Verellen and {De Ridder}, M.",

year = "2014",

language = "English",

journal = "Radiotherapy and Oncology",

issn = "0167-8140",

publisher = "Elsevier Ireland Ltd",

}

TY - JOUR

T1 - Phase II study of VERO SBRT for oligometastatic cancer: First clinical results

AU - Engels, B.

AU - Van den Begin, R.

AU - Depuydt, T.

AU - De Vin, T.

AU - Gevaert, T.

AU - Duchateau, M.

AU - Collen, C.

AU - Verellen, D.

AU - De Ridder, M.

PY - 2014

Y1 - 2014

UR - https://publons.com/wos-op/publon/53801396/

M3 - Article

SN - 0167-8140

JO - Radiotherapy and Oncology

JF - Radiotherapy and Oncology

ER -

Phase II study of VERO SBRT for oligometastatic cancer: First clinical results

Handle.net

Other files and links

Cite this